Validation of Non-electrophile Nrf2 Activators for WTC Relevant Pulmonary Indications скачать в хорошем качестве

Validation of Non-electrophile Nrf2 Activators for WTC Relevant Pulmonary Indications

Dr. Michael Cameron reviews his studies of Nrf2 activators, its regulatory properties, and indications for decreased pulmonary injury. Webinar recorded on August 11, 2022. Michael Cameron, PhD, is the Senior Scientific Director and Associate Professor of Molecular Medicine in the Department of Molecular Medicine at University of Florida Scripps Biomedical Research at ‪@UFHealth1‬. For more information about the WTC Health Program research, please visit us online https://www.cdc.gov/wtc/research.html. DISCLAIMER: Funding for this conference was made possible (in part) by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.